Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.
Pharma giants were responding to petition in Kerala HC seeking compulsory licences for their HER2-negative breast cancer drugs, which would allow cheaper, generic versions to be made.
Significant supplies of highly effective vaccines won’t be available until the end of 2021 & even once we have one, it probably won’t protect everyone, Narasimhan said.
If extremely heavy rainfall can cause such damage without a rare event like a cloudburst, it should leave the system working toward India’s disaster preparedness thinking.
One such website has drawn particular scrutiny for spreading fake stories that have upset not only the Indian but also foreign defence firms by falsely attributing misinformation.
COMMENTS